Your browser doesn't support javascript.
loading
Human Papillomavirus-Associated Invasive Condylomas in a Man with Immunosuppressive Comorbidities.
Zeuschner, Philip; Ueberdiek, Stefan; Pryalukhin, Alexey; Veith, Christian; Saar, Matthias; Smola, Sigrun; Bohle, Rainer Maria; Junker, Kerstin; Stöckle, Michael; Heinzelbecker, Julia.
Afiliación
  • Zeuschner P; Department of Urology and Pediatric Urology, Saarland University, Homburg, GermanyPhilip.zeuschner@uks.eu.
  • Ueberdiek S; Department of Urology and Pediatric Urology, Saarland University, Homburg, Germany.
  • Pryalukhin A; Institute of Pathology and Neuropathology, Saarland University, Homburg, Germany.
  • Veith C; Institute of Pathology and Neuropathology, Saarland University, Homburg, Germany.
  • Saar M; Department of Urology and Pediatric Urology, Saarland University, Homburg, Germany.
  • Smola S; Institute of Virology, Saarland University, Homburg, Germany.
  • Bohle RM; Institute of Pathology and Neuropathology, Saarland University, Homburg, Germany.
  • Junker K; Department of Urology and Pediatric Urology, Saarland University, Homburg, Germany.
  • Stöckle M; Department of Urology and Pediatric Urology, Saarland University, Homburg, Germany.
  • Heinzelbecker J; Department of Urology and Pediatric Urology, Saarland University, Homburg, Germany.
Urol Int ; 102(2): 238-242, 2019.
Article en En | MEDLINE | ID: mdl-30130762
ABSTRACT
Human papilloma virus (HPV) infections are one of the most common sexually transmitted diseases. We present the case of a 77-year-old Caucasian male with enormous genital warts of the penis, scrotum, groins and anus. Lesions were excised by electrosurgery. The histological examination revealed Condylomata gigantea as well as an invasive perianal squamous cell carcinoma. Mucosal "low-risk" HPV type 6 was detected. The patient had a history of an immunosuppressing disease. During the 4-year follow-up, multiple relapses occurred. Thus, particularly in immunosuppressed patients, early prophylactic HPV vaccination seems to be indicated for use in the prevention of HPV-associated mutilating and life-threatening disease. Vaccination should also protect from "low-risk" HPV.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Ano / Neoplasias del Pene / Infecciones Oportunistas / Carcinoma de Células Escamosas / Huésped Inmunocomprometido / Papillomavirus Humano 6 / Tumor de Buschke-Lowenstein Tipo de estudio: Diagnostic_studies / Risk_factors_studies Límite: Aged / Humans / Male Idioma: En Revista: Urol Int Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Ano / Neoplasias del Pene / Infecciones Oportunistas / Carcinoma de Células Escamosas / Huésped Inmunocomprometido / Papillomavirus Humano 6 / Tumor de Buschke-Lowenstein Tipo de estudio: Diagnostic_studies / Risk_factors_studies Límite: Aged / Humans / Male Idioma: En Revista: Urol Int Año: 2019 Tipo del documento: Article